AMA To Lobby For Physician Disclaimer On All Direct-To-Consumer Drug Ads
Executive Summary
The American Medical Association will lobby federal drug regulators for all DTC pharmaceutical ads to include a disclaimer noting that doctors might suggest an alternate drug.
You may also be interested in...
FDA Preclearance Of DTC Ads Included In Sen. Kennedy Draft Bill
Repeat offenders of direct-to-consumer advertising regulations would be required to submit all future ads to FDA for preclearance under a draft bill sponsored by Sen. Edward Kennedy (D-Mass.)
FDA Preclearance Of DTC Ads Included In Sen. Kennedy Draft Bill
Repeat offenders of direct-to-consumer advertising regulations would be required to submit all future ads to FDA for preclearance under a draft bill sponsored by Sen. Edward Kennedy (D-Mass.)
AMA Urges Expanded FDA Funding For DTC Oversight; Ban On Ads Rejected
The American Medical Association will advocate increased funding for FDA to more closely monitor direct-to-consumer advertising under a policy adopted by the AMA House of Delegates Dec. 5 in Orlando.